Contract SPE2DS22F0023
Orasure Technologies Inc · Department Of Defense · September 23, 2022
Orasure Technologies Inc was awarded a federal contract by Department Of Defense (Defense Logistics Agency) on September 23, 2022 for $388.44 million (current value) of work in pharmaceutical preparation manufacturing. Performance is in Bethlehem, PA. This is a task or delivery order issued under parent IDIQ SPE2DE21D0049. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 29, 2022. If all options are exercised, the contract could reach $388.44 million.
Contract details
- PIID
- SPE2DS22F0023
- Parent IDIQ
- SPE2DE21D0049
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition After Exclusion Of Sources
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Laboratory Equipment And Supplies
- Place of performance
- Bethlehem, PA
- First action
- September 23, 2022
- Latest action
- September 29, 2022
Description
8508632127!INTELISWAB COVID-19 ST OTC U
Modification timeline
-
September 29, 2022Mod P00017 · Change Order$388.44M
-
September 23, 2022Mod P00016 · Change Order$388.44M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $51 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $91 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $32 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $1.1K |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $22 |
| Cardinal Health, Inc. | Department Of Defense | December 31, 2025 | $23 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract SPE2DS22F0023?
Contract SPE2DS22F0023 is a federal contract awarded to Orasure Technologies Inc by Department Of Defense on September 23, 2022 for $388.44 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract SPE2DS22F0023?
Orasure Technologies Inc won contract SPE2DS22F0023 from Department Of Defense.
How much is contract SPE2DS22F0023 worth?
Contract SPE2DS22F0023 has obligated $0 to date but carries a potential ceiling of $388.44 million if fully funded and all options are exercised.